Published in Bioinformatics on November 13, 2011
The essential roles of chemistry in high-throughput screening triage. Future Med Chem (2014) 1.12
PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J Med Chem (2015) 1.10
Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates. J Med Chem (2013) 0.94
Determining the Degree of Promiscuity of Extensively Assayed Compounds. PLoS One (2016) 0.88
Vitexicarpin acts as a novel angiogenesis inhibitor and its target network. Evid Based Complement Alternat Med (2013) 0.85
Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited. Future Sci OA (2017) 0.85
How to Triage PAINS-Full Research. Assay Drug Dev Technol (2015) 0.83
A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation. PLoS One (2013) 0.80
Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS. J Chem Inf Model (2017) 0.80
Dealing with the Data Deluge: Handling the Multitude Of Chemical Biology Data Sources. Curr Protoc Chem Biol (2012) 0.76
Unveiling new biological relationships using shared hits of chemical screening assay pairs. Bioinformatics (2014) 0.75
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
NIH Molecular Libraries Initiative. Science (2004) 7.04
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem (2010) 6.54
Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science (1998) 4.15
The art of the chemical probe. Nat Chem Biol (2010) 3.85
PubChem as a public resource for drug discovery. Drug Discov Today (2010) 3.40
Target profiling of small molecules by chemical proteomics. Nat Chem Biol (2009) 3.20
Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol (2007) 2.90
Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput Biol (2009) 2.84
BioAssay ontology annotations facilitate cross-analysis of diverse high-throughput screening data sets. J Biomol Screen (2011) 1.44
A Java API for working with PubChem datasets. Bioinformatics (2011) 0.92
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01
A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature (2011) 4.44
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation. Nature (2011) 4.23
Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature (2011) 4.19
Probing protein ligand interactions by automated hydrogen/deuterium exchange mass spectrometry. Anal Chem (2006) 2.89
Partial agonists activate PPARgamma using a helix 12 independent mechanism. Structure (2007) 2.57
Molecular mimicry regulates ABA signaling by SnRK2 kinases and PP2C phosphatases. Science (2011) 2.52
The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol (2009) 2.30
TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell (2012) 2.03
Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands. J Biol Chem (2009) 2.02
Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer. Structure (2010) 1.96
Regulation of adipogenesis by natural and synthetic REV-ERB ligands. Endocrinology (2010) 1.88
Rapid analysis of protein structure and dynamics by hydrogen/deuterium exchange mass spectrometry. J Biomol Tech (2003) 1.85
HD desktop: an integrated platform for the analysis and visualization of H/D exchange data. J Am Soc Mass Spectrom (2008) 1.82
HDX workbench: software for the analysis of H/D exchange MS data. J Am Soc Mass Spectrom (2012) 1.80
A two-stage differential hydrogen deuterium exchange method for the rapid characterization of protein/ligand interactions. J Biomol Tech (2007) 1.65
DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol (2011) 1.59
Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators. Protein Sci (2006) 1.59
Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. Structure (2011) 1.54
Differential hydrogen/deuterium exchange mass spectrometry analysis of protein-ligand interactions. Expert Rev Proteomics (2011) 1.45
Dynamics of the beta2-adrenergic G-protein coupled receptor revealed by hydrogen-deuterium exchange. Anal Chem (2010) 1.38
Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method. Proc Natl Acad Sci U S A (2008) 1.38
Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity. J Biol Chem (2009) 1.30
Identification of SR2211: a potent synthetic RORγ-selective modulator. ACS Chem Biol (2012) 1.29
A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim Biophys Acta (2010) 1.28
Structural basis for basal activity and autoactivation of abscisic acid (ABA) signaling SnRK2 kinases. Proc Natl Acad Sci U S A (2011) 1.24
Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist. ACS Chem Biol (2010) 1.22
Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. Structure (2012) 1.21
Unique ligand binding patterns between estrogen receptor alpha and beta revealed by hydrogen-deuterium exchange. Biochemistry (2009) 1.18
Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity. Chem Biol (2012) 1.16
Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ. ACS Chem Biol (2010) 1.14
Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening. Mol Pharmacol (2008) 1.12
The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). J Biol Chem (2003) 1.12
Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics. Curr Opin Lipidol (2010) 1.09
Identification of a selective RORγ ligand that suppresses T(H)17 cells and stimulates T regulatory cells. ACS Chem Biol (2012) 1.04
Methods for the Analysis of High Precision Differential Hydrogen Deuterium Exchange Data. Int J Mass Spectrom (2011) 1.04
Biophysical mechanisms for large-effect mutations in the evolution of steroid hormone receptors. Proc Natl Acad Sci U S A (2013) 1.03
Time window expansion for HDX analysis of an intrinsically disordered protein. J Am Soc Mass Spectrom (2013) 1.02
Automated hydrogen/deuterium exchange electron transfer dissociation high resolution mass spectrometry measured at single-amide resolution. J Am Soc Mass Spectrom (2011) 1.01
Disorder-to-order transition underlies the structural basis for the assembly of a transcriptionally active PGC-1α/ERRγ complex. Proc Natl Acad Sci U S A (2011) 1.01
Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors. J Biol Chem (2011) 1.01
Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. J Alzheimers Dis (2012) 0.99
Apo-human carbonic anhydrase II revisited: implications of the loss of a metal in protein structure, stability, and solvent network. Biochemistry (2009) 0.98
Structural mobility in human manganese superoxide dismutase. Biochemistry (2006) 0.96
A combined ligand- and structure-based virtual screening protocol identifies submicromolar PPARγ partial agonists. ChemMedChem (2011) 0.94
The structural basis for recognition of base J containing DNA by a novel DNA binding domain in JBP1. Nucleic Acids Res (2011) 0.93
A Java API for working with PubChem datasets. Bioinformatics (2011) 0.92
Activation of AMP-activated protein kinase revealed by hydrogen/deuterium exchange mass spectrometry. Structure (2013) 0.91
Protein conformation ensembles monitored by HDX reveal a structural rationale for abscisic acid signaling protein affinities and activities. Structure (2013) 0.90
Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Nicotine Tob Res (2012) 0.88
Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model. Arthritis Rheumatol (2014) 0.88
Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain. J Biol Chem (2013) 0.88
Identification of a novel non-retinoid pan inverse agonist of the retinoic acid receptors. ACS Chem Biol (2011) 0.87
Inhibiting AMPylation: a novel screen to identify the first small molecule inhibitors of protein AMPylation. ACS Chem Biol (2013) 0.87
Improved crystallographic structures using extensive combinatorial refinement. Structure (2013) 0.87
Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations. J Biol Chem (2012) 0.85
Helix 11 dynamics is critical for constitutive androstane receptor activity. Structure (2011) 0.85
An antibody with a variable-region coiled-coil "knob" domain. Angew Chem Int Ed Engl (2013) 0.84
Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding. J Biol Chem (2013) 0.82
Identification of a small molecular insulin receptor agonist with potent antidiabetes activity. Diabetes (2014) 0.81
Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors. J Biol Chem (2013) 0.81
Small molecule amides as potent ROR-γ selective modulators. Bioorg Med Chem Lett (2012) 0.81
Assessing interactions between Ghsr and Mc3r reveals a role for AgRP in the expression of food anticipatory activity in male mice. Endocrinology (2014) 0.80
Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide. Arch Biochem Biophys (2003) 0.79
Mutual information identifies sequence positions conserved within the nuclear receptor superfamily: approach reveals functionally important regions for DNA binding specificity. Nucl Recept Signal (2011) 0.77
Hydrophobic Interactions Improve Selectivity to ERα for Ben-zothiophene SERMs. ACS Med Chem Lett (2012) 0.77
High-throughput analysis of protein structure by hydrogen/deuterium exchange mass spectrometry. Methods Biochem Anal (2005) 0.77
RORs in autoimmune disease. Curr Top Microbiol Immunol (2014) 0.76
Efficient methodology for the synthesis of 3-amino-1,2,4-triazoles. J Org Chem (2009) 0.75
Corrigendum: CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. Nature (2016) 0.75
Development of an HTS-compatible assay for discovery of RORα modulators using AlphaScreen® technology. J Biomol Screen (2011) 0.75
Effect of signal interference from dosing excipients on pharmacokinetic screening of drug candidates by liquid chromatography/mass spectrometry. Anal Chem (2002) 0.75
Erratum: Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nat Chem Biol (2017) 0.75
Corrigendum: Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nat Chem Biol (2017) 0.75